Boston Therapeutics (OTC BB: BTHE) and Xinergy (TSX: XRG) Lead the Top Sector Gainers

Published:

Boston Therapeutics Inc (OTC BB: BTHE) and Xinergy Ltd (TSX: XRG), lead the top small cap stock gainers for various sectors on both sides of the border, including one that saw its share price surge 65%.

Top U.S. Gainer

Company Name

Exchange

Ticker

Market Cap
($ Mn)

Last Price

Last Volume

Price Return
(1-Day)

Price Return
(5-Days)

52-Week High

52-Week Low

Boston Therapeutics Inc

OTC BB

BTHE

24.6

0.64

113,026

39.1%

166.6%

1.67

0.16

Boston Therapeutics Inc (OTC BB: BTHE), engaged in developing, manufacturing and commercializing therapeutic drugs with a focus on complex carbohydrate chemistry to address diabetes and inflammatory diseases, was the top performer in the U.S. healthcare sector after climbing 39.1% and closed at $0.64 Monday, while recording significant trading volumes of 113,026 shares. BTHE breached its key technical resistance level of 200-Day DMA at $0.56. Recently, BTHE announced that the U.S. Food and Drug Administration (“FDA”) has accepted the company’s Investigational New Drug Application (“IND”) for BTI-320 to treat Type 2 diabetes and weight management. During the past 5-trading sessions, BTHE gained 166.6% with daily average trading volumes of 60,447 shares, while the stock accumulated 216.8% gain during the past one month with daily average trading volumes of 15,574 shares.

1-Year Price Chart

Top Canadian Gainer

Company Name

Exchange

Ticker

Market Cap
(C$ Mn)

Last Price

Last Volume

Price Return
(1-Day)

Price Return
(5-Days)

52-Week High

52-Week Low

Xinergy Ltd

TSX

XRG

11.1

0.19

112,577

65.2%

111.1%

0.70

0.06

Xinergy Ltd (TSX: XRG), engaged in the business of mining bituminous steam coal in the central Appalachia region, was the top sector gainer after skyrocketing 65.2% and closed at C$0.19 Monday, while recording significant trading volumes of 112,577 shares. XRG broke its key technical resistance level of 30-Day DMA at C$0.19. The stock’s price rise is attributable to the company’s announcement that it will cure the previously announced default on the company’s 9.25% senior secured notes by making payment of approximately US$9 million in interest owed on the notes with the help of cash generated from operations. During the past 5-trading sessions, XRG gained 111.1% with daily average trading volumes of 129,598 shares, while the stock fell by 29.6% during the past one month with daily average trading volumes of 81,583 shares.

1-Year Price Chart

Related articles

Recent articles